Picture of Vericel logo

VCEL — Vericel News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Vericel Corp expected to post a loss of 12  cents a share - Earnings Preview

* Vericel Corp  VCEL.OQ   VCEL.O  is expected to show a rise
in
quarterly revenue when it reports  results on May 4. 
    * The Cambridge Massachusetts-based  company is expected to
report
 a 2.0% increase in revenue to $34.312 million from $33.63
million a year ago, according to the mean estimate from 6
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Vericel Corp is for
a
loss of 12 cents per share. For the same quarter last year, the
company reported a loss of 7 cents per share.
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts had fallen by
about 9.5%
in the last three months. ​
    * Wall Street's median 12-month price target for Vericel
Corp is
$49​, above​ its last closing price of $28.50. ​​​
    * Previous quarterly performance (using preferred earnings
measure
in US dollars). ​

 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2021  0.15        0.14       0.09      Missed  -37.2
 Sep. 30 2021  -0.03       -0.03      -0.11     Missed  -305.3
 Jun. 30 2021  -0.09       -0.08      -0.08     Met     4.5​
 Mar. 31 2021  -0.04       -0.04      -0.07     Missed  -66.2
 ​​Dec.        0.20        0.20       0.25      Beat    23.5
 31 2020                                                
 Sep. 30 2020  -0.07       -0.06      0.08      Beat    223.9​
 Jun. 30 2020  -0.18       -0.21      -0.18     Beat    12.9
 Mar. 31 2020  -0.08       -0.08      -0.10     Missed  -22.4
 This summary was machine generated May 2 at 18:31 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Vericel

See all news